Detection of Ciprofloxacin-Resistant, β-Lactamase-Producing Neisseria meningitidis Serogroup Y Isolates - United States, 2019-2020.


Journal

MMWR. Morbidity and mortality weekly report
ISSN: 1545-861X
Titre abrégé: MMWR Morb Mortal Wkly Rep
Pays: United States
ID NLM: 7802429

Informations de publication

Date de publication:
19 Jun 2020
Historique:
entrez: 20 6 2020
pubmed: 20 6 2020
medline: 23 6 2020
Statut: epublish

Résumé

Meningococcal disease is a sudden-onset, life-threatening illness caused by the bacterium Neisseria meningitidis. Prompt empiric antibiotic treatment can reduce morbidity and mortality among patients, and antibiotic prophylaxis can prevent secondary disease in close contacts. Historically, N. meningitidis isolates in the United States have largely been susceptible to the antibiotics recommended for treatment and prophylaxis, including penicillin and ciprofloxacin. This report describes detection of penicillin-resistant and ciprofloxacin-resistant N. meningitidis serogroup Y (NmY) isolates in the United States. NmY isolates containing a bla

Identifiants

pubmed: 32555137
doi: 10.15585/mmwr.mm6924a2
pmc: PMC7302475
doi:

Substances chimiques

Ciprofloxacin 5E8K9I0O4U
beta-Lactamases EC 3.5.2.6

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

735-739

Investigateurs

Nirmala Dhungana (N)
Ryan Gabrio-Brannon (R)
Jennifer Kyle (J)
Brittany Martin (B)
Meghan Barnes (M)
Ashley Moore (A)
Susan Hannagan (S)
Page Keating (P)
Sandy Li (S)
Justin Albertson (J)
Wayne Fleming (W)
Perrianne Lurie (P)
Christina Russell (C)
Kara Reid (K)
Kelsey Sanders (K)
Chas DeBolt (C)
Nicholas Graff (N)
Esther Lam (E)
Benjamin Hanisch (B)
Gillian Taormina (G)

Déclaration de conflit d'intérêts

All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.

Références

MMWR Morb Mortal Wkly Rep. 2008 Feb 22;57(7):173-5
pubmed: 18288075
N Engl J Med. 2009 Feb 26;360(9):886-92
pubmed: 19246360
J Antimicrob Chemother. 2019 Jan 1;74(1):22-28
pubmed: 30295754
Open Forum Infect Dis. 2016 Jul 13;3(3):ofw152
pubmed: 27704009
Antimicrob Agents Chemother. 2007 Jun;51(6):2260-4
pubmed: 17438055
MMWR Recomm Rep. 2013 Mar 22;62(RR-2):1-28
pubmed: 23515099
Open Forum Infect Dis. 2015 Aug 13;2(3):ofv117
pubmed: 26357666
Antimicrob Agents Chemother. 2018 Aug 27;62(9):
pubmed: 29941641

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH